Skip to main content
OpenTrials
Completed

NCT Number: NCT06307730

Application of the Recommendations of the SPLIF (French Society of Infectious Pathology) in a Geriatric Population on the Duration of Treatment for Bacterial Pneumonia

Pneumopathy is the leading cause of death from infectious disease in the elderly. Prior to 2021, the recommended duration of antibiotic therapy for pneumonia, in adults, was 7 days.

Two theses have shown that these recommendations were poorly applied in geriatric services. Indeed, the duration of treatment exceeded 7 days, and less than 30% of antibiotic antibiotic treatments were re-evaluated at 72 hours.

In 2021, the SPLIF ( published new recommendations reducing this duration to 5 days in the event of clinical improvement observed on the 3rd day of treatment. These new recommendations are based on studies, in which the average age of participants was 65 years. However, the average age of patients in geriatric short-stay departments is 84.7 years.

In addition, the geriatric population is characterized by immunosenescence, pulmonary vulnerability and undernutrition, raising questions about the validity of these recommendations in the geriatric population.

The investigators offer a monocentric, retrospective, observational study of the geriatric hospital Casanova to assess the application of SPLIF recommendations in the geriatric population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pneumonia, Bacterial Bacterial Infections Bacterial Infections and Mycoses Infections Lung Diseases Pneumonia Pneumopathy Respiratory Tract Diseases Respiratory Tract Infections

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hopitalier de Saint-Denis

Saint-Denis, Seine Saint Denis, 93200, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patient treated for bacterial/community/nosocomial pneumonia who stayed in the geriatric short-stay at Casanova's Hospital between January 2, 2023 and April 30, 2023

Exclusion criteria

  • HIV Positif
  • Immunosupressed patient
  • Complicated pneumonia (abcess, pleuropneumonia)

Treatment and study plan

Primary outcomes

  1. Sex

    Time frame: Day 1

  2. Age

    Time frame: Day 1

  3. Weight

    Time frame: Day 1

  4. Phone Number

    Time frame: Day 1

  5. Origins

    Time frame: Day 1

    Coming from Home, An institution...

  6. Autonomy in daily life's score before hospitalisation

    Time frame: Day 1

    score between 0 (autonomous) and 6 (dependent)

  7. Charlson's morbidity score

    Time frame: Day 1

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Saint-Denis

Other

Registry information

Official study title

Duration of Antibiotic Treatment for Infectious Pneumonia in Eldery Subjects

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 13, 2024
Registry last updated
Mar 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.